XML 49 R32.htm IDEA: XBRL DOCUMENT v3.7.0.1
Income Taxes (Tables)
 3 Months Ended
Mar. 31, 2017
Income taxes  
Schedule of income tax expense (benefit) associated with significant operating and nonoperating items for the interim periods presented
The following table illustrates the income tax expense (benefit) associated with significant operating and nonoperating items for the interim periods presented (in millions):
 
Three Months Ended
 
 
March 31, 2017

 
April 1,
2016

 
Asset impairments
$
—

1 
$
—

 
Productivity and reinvestment program
(52
)
2 
(21
)
2 
Other productivity, integration and restructuring initiatives
—


—

3 
Transaction gains and losses
(174
)
4 
(143
)
5 
Certain tax matters
(30
)
6 
(6
)
7 
Other — net
(17
)
8 
(1
)
9 
1 
Related to charges of $104 million due to the impairment of certain of the Company's intangible assets. Refer to Note 10 and Note 14.
2 
Related to charges of $139 million and $63 million during the three months ended March 31, 2017 and April 1, 2016, respectively. These charges were due to the Company's productivity and reinvestment program. Refer to Note 10 and Note 11.
3 
Related to charges of $199 million during the three months ended April 1, 2016. These charges were due to the integration of our German bottling operations. Refer to Note 10 and Note 11.
4 
Related to charges of $665 million primarily on pretax charges of $497 million as a result of the refranchising of certain bottling territories in North America, $57 million related to costs incurred to refranchise certain of our bottling operations and charges of $106 million primarily related to payments made to convert certain North America bottling partners' territories to a single form of CBA with additional requirements. Refer to Note 2 and Note 10.
5 
Related to a net charge of $397 million that primarily included $369 million of charges primarily due to the refranchising of bottling territories in North America and $45 million related to costs incurred to refranchise certain of our bottling operations, partially offset by an $18 million gain related to the disposal of our investment in Keurig. Refer to Note 2 and Note 10.
6 
Related to $53 million of excess tax benefits associated with the Company's share-based compensation arrangements partially offset by changes to our uncertain tax positions, including interest and penalties. The components of the net change in uncertain tax positions were individually insignificant.
7 
Primarily related to amounts required to be recorded as a result of a tax rate change in Japan and for changes to our uncertain tax positions, including interest and penalties. The components of the net change in uncertain tax positions were individually insignificant.
8 
Related to charges of $64 million that included a $58 million net charge due to our proportionate share of significant operating and nonoperating items recorded by certain of our equity method investees and a $6 million charge due to tax litigation expense. Refer to Note 10.
9 
Related to charges of $6 million that included a $3 million net charge due to our proportionate share of significant operating and nonoperating items recorded by certain of our equity method investees and a $3 million charge due to tax litigation expense. Refer to Note 10.